SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    U.S. Cancer Statistics Working Group. United States cancer statistics: 2002 Incidence and mortality web-based report version. Centers for Disease Control and Prevention, and National Cancer Institute, 2005. Available at http://www.cdc.gov/cancer/npcr/uscs, http://seer.cancer.gov/statistics, accessed January 18, 2006.
  • 2
    American Cancer Society. Colorectal cancer facts & figures special edition 2005. American Cancer Society, 2005. Available at http://www.cancer.org/docroot/STT/stt_0.asp, accessed December 21, 2005.
  • 3
    Institute of Medicine (IOM),National Research Council,National Cancer Policy Board. Fulfilling the Potential of Cancer Prevention and Control. Washington, DC: The National Academics Press; 2003.
  • 4
    U.S. Preventive Services Task Force. Screening for colorectal cancer: Recommendations and rationale. Agency for Healthcare Research and Quality, 2002. Available at http://www.ahrq.gov/clinic/3rduspstf/colorectal/colorr.htm, accessed January 10, 2006.
  • 5
    U.S. Cancer Statistics Working Group. United States cancer statistics: 2001 Incidence and mortality web-based report version. Centers for Disease Control and Prevention, National Cancer Institute, 2004. Available at URL: http://www.cdc.gov/cancer/npcr/uscs, http://seer.cancer.gov/statistics, accessed January 18, 2006.
  • 6
    Hankey BF, Ries LA, Edwards BK. The surveillance, epidemiology, and end results program: A national resource. Cancer Epidemiol Biomarkers Prev. 1999; 8: 11171121.
  • 7
    Hotes JL, Wu X-C, McLaughlin C, et al. Cancer in North America, 1996–2000, Vol 1:Incidence. North American Association of Central Cancer Registries; 2003. Available at http://www.naaccr.org/index.asp?Col_SectionKey=11&Col_ContentID=346, accessed December 8, 2005.
  • 8
    World Health Organization. Cancer Incidence in Five Continents, Vol. 8. Lyon: IARC Press; 2002. IARC Scientific Publication No. 155.
  • 9
    Schottenfeld D, Winawere SJ. Cancers of the large intestine. In: SchottenfeldD, FraumeniJFJr, eds. Cancer Epidemiology and Prevention, 2nd edn. New York: Oxford University Press; 1996: 813840.
  • 10
    Stewart SL, Wike JM, Kato I, Lewis DR, Michaud F. A population-based study of colorectal cancer histology in the United States, 1998–2001. Cancer. 2006.
  • 11
    Davies RJ, Miller R, Coleman N. Colorectal cancer screening: Prospects for molecular stool analysis. Nat Rev Cancer. 2005; 5: 199209.
  • 12
    Hawk ET, Levin B. Colorectal cancer prevention. J Clin Oncol. 2005; 23: 378391.
  • 13
    Winawer SJ. Screening of colorectal cancer: Progress and problems. Recent Results Cancer Res. 2005; 166: 231244.
  • 14
    Labianca R, Beretta GD, Mosconi S, Milesi L, Pessi MA. Colorectal cancer: Screening. Ann Oncol. 2005; 16 ( Suppl 2): ii127ii132.
  • 15
    Ries LAG, Eisner MP, Kosary CL. SEER cancer statistics review, 1975–2001. National Cancer Institute, 2004. Available at http://seer.cancer.gov/csr/1975_2001, accessed September 18, 2005.
  • 16
    Skibber JM, Minsky BD, Hoff PM. Cancer of the colon. In: DeVitaVTJr, HellmanS, RosenbergSA, eds. Cancer: Principles & Practice of Oncology, 6th edn. Philadelphia: Lippincott Williams & Wilkins; 2001: 12161271.
  • 17
    Tomeo CA, Colditz G, Willett WC. Harvard report on cancer prevention, Vol. 3: Prevention of colon cancer in the United States. Cancer Causes Control. 1999;10: 167180.
  • 18
    O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY. Rates of colon and rectal cancers are increasing in young adults. Am Surg. 2003; 69: 866872.
  • 19
    O'Connell JB, Maggard MA, Livingston EH, Yo CK. Colorectal cancer in the young. Am J Surg. 2004; 187: 343348.
  • 20
    Fairley TL, Cardinez CJ, Martin J, et al. Colorectal cancer in United States adults younger than 50 years of age, 1998–2001. Cancer. 2006.
  • 21
    Coughlin SS, Richards TB, Thompson T, et al. Rural/non-rural differences in colorectal cancer incidence in the United States, 1998–2001. Cancer. 2006.
  • 22
    Cress RD, Morris C, Ellison GL, Goodman MT. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis and race/ethnicity, 1992–2001. Cancer. 2006.
  • 23
    Lai S-M, Zhang KB, Uhler RJ, Harrison JN, Clutter GG, Williams MA. Regional variation in the incidence of colorectal cancer in the United States, 1998–2001. Cancer. 2006.
  • 24
    Matanoski G, Tao X, Almon L, Adade AA, Davies-Cole JO. Characteristics of colorectal cancers in the United States, 1998–2001. Cancer. 2006.
  • 25
    Wu X, Cokkinides V, Chen VW, et al. Association of subsite-specific colorectal cancer incidence rate and stage at diagnosis with county-poverty level, 1998–2001. Cancer. 2006.
  • 26
    Edwards BK, Brown ML, Wingo P, et al. Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005; 97: 14071427.
  • 27
    Rex DK, Rawl SM, Rabeneck L, Rex EK, Hamilton F. Colorectal cancer in African Americans. Rev Gastroenterol Disord. 2004; 4: 6065.
  • 28
    Palmer RC, Schneider EC. Social disparities across the continuum of colorectal cancer: A systematic review. Cancer Causes Control. 2005; 16: 5561.
  • 29
    Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer. 2004; 101: 327.
  • 30
    American Cancer Society. Cancer facts & figures for African Americans 2005–2006. American Cancer Society, 2005. Available at http://www.cancer.org/docroot/STT/stt_0.asp, accessed November 8, 2005.
  • 31
    Ghafoor A, Jemal A, Cokkinides V, et al. Cancer statistics forAfrican Americans. CA Cancer J Clin. 2002; 52: 236341.
  • 32
    Rex DK, Johnson DA, Lieberman DA, Burt RWSA. Colorectal cancer prevention 2000: Screening recommendations of the American College of Gastroenterology. Am J Gastroenterol. 2000; 95: 868877.
  • 33
    Kahi CJ, Rex DK. Screening and surveillance of colorectal cancer. Gastrointest Endosc Clin N Am. 2005; 15: 533547.
  • 34
    Kahi CJ, Rex DK. Current and future trends in colorectal cancer screening. Cancer Metastasis Rev. 2004; 23: 137144.
  • 35
    Walsh JM, Terdiman JP. Colorectal cancer screening: Scientific review. JAMA. 2003; 289: 12881296.
  • 36
    Centers for Disease Control and Prevention. Screening to prevent cancer deaths. Centers for Disease Control and Prevention, 2006. Available at http://www.cdc.gov/nccdphp/publications/factsheets/prevention/cancer.htm, accessed January 11, 2006.
  • 37
    Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004; 100: 20932103.
  • 38
    Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE. Noninvasive testing for colorectal cancer: A review. Am J Gastroenterol. 2005; 100: 13931403.
    Direct Link:
  • 39
    Levin B, Brooks D, Smith RA, Stone A. Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J Clin. 2003; 53: 4455.
  • 40
    Wingo PA, Jamison PM, Hiatt RA, et al. Building the infrastructure for nationwide cancer surveillance and control––A comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control. 2003; 14: 175193.
  • 41
    FritzA, RiesL, eds. The SEER Program Code Manual, 3rd edn. Bethesda, MD: National Cancer Institute, NIH; 1998.
  • 42
    World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death (based on the recommendations of the Ninth Revision Conference on International Classification, 1975). Geneva, Switzerland: World Health Organization; 1977.
  • 43
    World Health Organization. International Statistical Classification Of Diseases and Related Health Problems, 10th rev. Geneva, Switzerland: World Health Organization; 1992.
  • 44
    Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System. Centers for Disease Control and Prevention, 2005. Available at http://www.cdc.gov/brfss/, accessed November 8, 2005.
  • 45
    US Census Bureau. United States Census 2000 Summary File 4 (SF 4). US Census Bureau, 2003. Available at http://www.census.gov/Press-Release/www/2003/SF4.html, accessed June 30, 2004.
  • 46
    US Department of Agriculture. Measuring rurality: Rural–urban continuum codes. US Department of Agriculture, 2003. Available at http://www.ers.usda.gov/briefing/rurality/RuralUrbCon, accessed June 30, 2004.
  • 47
    National Cancer Institute, Surveillance Research Program, Cancer Statistics Branch. SEER*Stat Database (Version Released: April 2004) based on the November 2003 Submission. Surveillance, Epidemiology, and End Results (SEER) Program, 2004, National Cancer Institute. Available at http://www.seer.cancer.gov/publicdata, accessed June 30, 2004.
  • 48
    International Classification of Diseases for Oncology, 3rd edn. Geneva, Switzerland: World Health Organization; 2000.
  • 49
    SEER incidence site recode. Site recode ICD-O-3 (1/27/2003). Surveillance, Epidemiology, and End Results (SEER) Program, 2003, National Cancer Institute. Available at http://seer.cancer.gov/siterecode, accessed November 8, 2005.
  • 50
    International Classification of Diseases for Oncology, 2nd edn. Geneva, Switzerland: World Health Organization; 1990.
  • 51
    Conversion programs, ICD-O-2 to 3 and ICD-O-3 to 2. Surveillance, Epidemiology, and End Results (SEER) Program, 2004, National Cancer Institute. Available at http://www.seer.cancer.gov/tools/conversion, accessed November 8, 2005.
  • 52
    Surveillance, Epidemiology, and End Results Program. Summary Staging Guide for the Cancer Surveillance, Epidemiology, and End Results (SEER) Program. Bethesda, MD: National Institutes of Health, National Cancer Institute; 1977.
  • 53
    Surveillance, Epidemiology, and End Results Program. Summary Staging Manual 2000. Bethesda, MD: National Institutes of Health, National Cancer Institute; 2005.
  • 54
    SEER cause of death recode. COD recode 1950+ (4/15/2002). Surveillance, Epidemiology, and End Results (SEER) Program, 2002, National Cancer Institute. Available at URL: http://seer.cancer.gov/codrecode, accessed November 8, 2005.
  • 55
    Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: A method based on the gamma distribution. Stat Med. 1997; 16: 791801.
  • 56
    SEER*Stat software. Surveillance Research Program, 2005, National Cancer Institute. Available at http://www.seer.cancer.gov/seerstat, accessed November 8, 2005.
  • 57
    O'Malley AS, Hu K, West D. North American Association of Central Cancer Registries: Race and ethnicity identifier assessment project. North American Association of Central Cancer Registries, 2003; 255. Available at http://www.naaccr.org/index.asp?Col_SectionKey=11&Col_ContentID=52, accessed December 8, 2005.
  • 58
    NAACCR Expert Panel on Hispanic Identification. Report of the NAACCR expert panel on Hispanic identification 2003. North American Association of Central Cancer Registries, 2003. Available at URL: http://www.naaccr.org/index.asp?Col_SectionKey=11&Col_ContentID=52, accessed December 8, 2005.
  • 59
    Ahmed F, Goodman M, Kosary C, et al. Excess risk of subsequent primary cancers among colorectal carcinoma survivors, 1975–2001. Cancer. 2006.
  • 60
    Parikh-Patel A, Campleman S, Bates JH. Colorectal cancer stage at diagnosis by socioeconomic and urban/rural status in California, 1998–2000. Cancer. 2006.
  • 61
    Coughlin SS, Costanza ME, Fernandez ME, et al. CDC-funded intervention research aimed at promoting colorectal cancer screening in communities. Cancer. 2006.